Maansi Bansal-Travers

Associate Professor of Oncology

Roswell Park Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Maansi Bansal-Travers is an Associate Professor of Oncology at Roswell Park Comprehensive Cancer Center in the United States. Her research focuses on tobacco control, including health warning labels, sexual orientation and gender identity data collection in cancer patients, and the perceptions of nicotine replacement therapies among smokers. She has contributed significantly to the understanding of tobacco product use patterns and cessation correlates through various studies and publications.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Andrea Villanti

Associate Professor

Rutgers University

UNITED STATES

View details

MeLisa Creamer

National Institute on Drug Abuse

UNITED STATES

View details

Bibha Dhungel

University of Melbourne

AUSTRALIA

View details

Coral Gartner

Professorial Research Fellow

University of Queensland

AUSTRALIA

View details

Andrew J. Barnes

UNITED STATES

View details

Katherine East

Associate Professor

Brighton and Sussex Medical School

UNITED KINGDOM

View details

Ann McNeill

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maansi Bansal-Travers

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Trends in noticing and responding to, health warning labels on cigarette packages among adults who smoke

Developing, implementing, and disseminating best practices for enhanced collection of sexual orientation and gender identity among cancer patients to catalyze innovative cancer control research

Patterns of Premium and Nonpremium Cigar Use in the United States: Findings from Wave 6 (2021) of the Population Assessment of Tobacco and Health Study

Common Measures to Evaluate Flavored Tobacco Products: Recommendations From the Tobacco Centers for Regulatory Science (TCORS) Flavored Tobacco Products Measurement Subcommittee

Do Smokers’ Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys

Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’)

Developing Graphic Messages for Vaping Prevention Among Black and Latino Adolescents: Participatory Research Approach

Smokers’ perceptions of different classes of cigarette brand descriptors

Correlates of tobacco product cessation among youth and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016)

Correlates of tobacco product reuptake and relapse among youth and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016)

Longitudinal pathways of exclusive and polytobacco cigar use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016)

Longitudinal pathways of exclusive and polytobacco hookah use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016)

Collaborators (7)

Andrea Villanti

MeLisa Creamer

Bibha Dhungel

Coral Gartner

Andrew J. Barnes

Katherine East

Ann McNeill

Make your next move.